Sanara MedTech Inc (SMTI)
30.47
-1.23
(-3.88%)
USD |
NASDAQ |
May 17, 16:00
30.47
0.00 (0.00%)
After-Hours: 20:00
Sanara MedTech Cash from Financing (Quarterly): -0.6588M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.6588M |
| December 31, 2023 | -0.1859M |
| September 30, 2023 | 9.225M |
| June 30, 2023 | 0.5066M |
| March 31, 2023 | 0.0958M |
| December 31, 2022 | -0.3044M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.22M |
| March 31, 2022 | -0.1029M |
| December 31, 2021 | -0.4425M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 28.74M |
| December 31, 2020 | 0.0131M |
| September 30, 2020 | 0.0262M |
| June 30, 2020 | 0.583M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 7.80M |
| September 30, 2019 | 1.00M |
| June 30, 2019 | 0.50M |
| March 31, 2019 | 0.50M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0003M |
| September 30, 2017 | -0.0011M |
| June 30, 2017 | -0.1192M |
| March 31, 2017 | -0.0239M |
| December 31, 2016 | -0.0288M |
| September 30, 2016 | -0.0521M |
| June 30, 2016 | 0.0879M |
| March 31, 2016 | 0.2379M |
| December 31, 2015 | 0.1869M |
| September 30, 2015 | 0.2371M |
| June 30, 2015 | 0.4451M |
| March 31, 2015 | -0.002M |
| December 31, 2014 | -0.0109M |
| September 30, 2014 | -0.0009M |
| June 30, 2014 | 0.1796M |
| March 31, 2014 | 2.006M |
| December 31, 2013 | 0.5801M |
| September 30, 2013 | 0.1214M |
| June 30, 2013 | 0.1854M |
| March 31, 2013 | 0.9637M |
| December 31, 2012 | -0.0497M |
| September 30, 2012 | 0.4618M |
| June 30, 2012 | 0.2019M |
| March 31, 2012 | 0.2825M |
| December 31, 2011 | 0.0399M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.6588M
Minimum
Mar 2024
28.74M
Maximum
Mar 2021
2.329M
Average
0.0066M
Median
Cash from Financing (Quarterly) Benchmarks
| AptarGroup Inc | -35.75M |
| Daxor Corp | -- |
| Precision Optics Corp Inc | -0.1363M |
| Warby Parker Inc | 0.091M |
| Perspective Therapeutics Inc | 0.352M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.594M |
| Cash from Investing (Quarterly) | -0.0658M |
| Free Cash Flow | -3.402M |
| Free Cash Flow Per Share (Quarterly) | -0.1972 |
| Free Cash Flow to Equity (Quarterly) | -1.663M |
| Free Cash Flow Yield | -1.34% |